Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen–progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women
- 21 March 1997
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 129 (2) , 249-259
- https://doi.org/10.1016/s0021-9150(96)06036-4
Abstract
No abstract availableKeywords
Funding Information
- Sigrid Juséliuksen Säätiö
- Helsingin Yliopisto
- Helsingin ja Uudenmaan Sairaanhoitopiiri
This publication has 50 references indexed in Scilit:
- ApoA-IHelsinki(Lys107→0) Associated With Reduced HDL Cholesterol and LpA-I:A-II DeficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of transdermal 17β-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal womenJournal of Internal Medicine, 1993
- Regulation of apolipoprotein A-I-containing lipoproteins in IDDMDiabetes, 1993
- Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal womenThe American Journal of Cardiology, 1992
- Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Mechanism of the hepatic lipase-induced accumulation of high-density lipoprotein cholesterol by cells in cultureBiochemistry, 1985
- Subpopulations of apolipoprotein A-I in human high-density lipoproteins their metabolic properties and response to drug therapyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Electrophoresis in polyacrylamide concentration gradientBiochemical and Biophysical Research Communications, 1967